Our findings are in agreement with a recent publication identifying the SWI/SNF subunit member SMARCB1 as required to target the SWI/SNF to specific enhancer regions and provide new insights into BRD proteins to a cancer-related SWI/SNF function. Here, SMARCB1 is linked to cancer.